Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

166 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

NCT01638000

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site: 37406 Yerevan, Armenia
  • Site: 37404 Yerevan, Armenia
  • Site: 37403 Yerevan, Armenia
  • Site: 37401 Yerevan, Armenia
View all 217 locations
View Trial Details
Completed

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin)

NCT01908829

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Genova Clinical Research Tucson, Arizona, United States
  • Associated Pharmaceutical Research Center, Inc. Buena Park, California, United States
  • The American Institute of Research Los Angeles, California, United States
  • Bayview Research Group Valley Village, California, United States
View all 219 locations
View Trial Details
Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice

NCT02320773

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations
  • Site CZ42009 UROMEDA s. r. o. Brno, Czechia
  • Site CZ42003 Fakultni nemocnice Brno-Bohunice Brno, Czechia
  • Site CZ42006 Hospital Kyjov Kyjov, Czechia
  • Site CZ42002 Fakultni nemocnice Kralovske Vinohrady Prague, Czechia
View all 60 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder

NCT01340027

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • BY37101 Minsk, Belarus
  • BY37102 Minsk, Belarus
  • BY37103 Minsk, Belarus
  • BY37104 Vitebsk, Belarus
View all 133 locations
View Trial Details
Completed

A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)

NCT02386072

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Site US1051 Birmingham, Alabama, United States
  • Site US1094 Birmingham, Alabama, United States
  • Site US1010 Huntsville, Alabama, United States
  • Site US1020 Mobile, Alabama, United States
View all 92 locations
View Trial Details
Completed

Audit-and-feedback to Improve Antimicrobial-prescribing Among Urologists

NCT04196777

Conditions
Antibacterial Drug Adverse Reaction, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +3 more
Locations
  • VA North Florida/South Georgia Veterans Health System Gainesville, Florida, United States
  • Iowa City VA Medical Center Iowa City, Iowa, United States
  • VA New York Harbor Healthcare System (Brooklyn) New York, United States
View Trial Details

Related conditions